Vérification…
Traduit automatiquement. Doses et mises en garde : vérifiez l'original en anglais. Lire en anglais
Accueil / Enregistré au Nigeria / 10% DEXTROSE INFUSION $

10% DEXTROSE INFUSION $

NAFDAC REG NO: A11-0237 Médicament

Enregistré auprès de NAFDAC. Enregistrement actifAs of 1 November 2026 · synced automatically from official sources.
Produit
10% DEXTROSE INFUSION $
Numéro NAFDAC
A11-0237
Principe actif
Dextrose Anhydrous
Dosage
10%
Forme
Solution for infusion
Conditionnement
500 mL
Fabricant
Non répertorié
Déposant / Titulaire :
Fidson Healthcare PLC
Approuvé
28 Oct 2021
Statut
Inactive Vue sur NAFDAC ↗
Enregistrement valable jusqu'au
27 Oct 2026
Alertes OMS
Non trouvé
Community reports
None
Times checked
0

About the medicine: Dextrose anhydrous: uses, dosage and brands worldwide

What we found

  • 10% DEXTROSE INFUSION $ is on the NAFDAC register with an active registration (A11-0237). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use 10% DEXTROSE INFUSION $

Ce que dit la notice officielle. Si un médecin vous l'a prescrit, suivez l'ordonnance. La notice de votre boîte prime si elle est différente.

Pour qui

1. INDICATIONS AND USAGE 10% Dextrose Injection is indicated as source of water and calories.

Comment le prendre et à quelle fréquence
  • Important Administration Instructions 10% Dextrose Injection is intended for intravenous use
  • Peripheral administration of 5% dextrose is generally acceptable, however, consider central vein when administering more than 5% dextrose or with an osmolarity of at least 900 mOsm/L or when there is peripheral vein irritation, phlebitis, and/or associated pain [see Warnings and Precautions ]
  • Do not administer 10% Dextrose Injection simultaneously with blood products through the same administration set because of the possibility of pseudoagglutination or hemolysis
  • To prevent air embolism, use a non-vented infusion set or close the vent on a vented set, avoid multiple connections, do not connect flexible containers in series, fully evacuate residual gas in the container prior to administration, do not pressurize the flexible container to increase flow rates, and if administration is controlled by a pumping device, turn off pump before the container runs dry
  • Prior to infusion, visually inspect the diluted dextrose solution for particulate matter
  • The solution should be clear and there should be no precipitates
  • Do not administer unless solution is clear and container is undamaged
  • Use of a final filter is recommended during administration of parenteral solutions, where possible
  • Recommended Dosage The choice of dextrose concentration, rate and volume depends on the age, weight, clinical and metabolic conditions of the patient and concomitant therapy
  • Electrolyte supplementation may be indicated according to the clinical needs of the patient. …
Strengths it comes in

Injection: 10% (0.1 grams/mL): 10 grams of dextrose hydrous per 100 mL in flexible containers: 250 mL, 500 mL, and 1000 mL. (3)

Talk to a doctor first if
  • Clinically significant hyperglycemia
  • Known hypersensitivity to dextrose
Medicines it may not mix with

Other Products that Affect Glycemic Control, Vasopressin or Fluid and/or Electrolyte Balance: Monitor blood glucose concentrations, fluid balance, serum electrolyte concentrations and acid-base balance. (7.1) Pediatric Use: Increased risk of hypoglycemia/hyperglycemia; monitor serum glucose concentrations. (8.4) See 17 for PATIENT COUNSELING INFORMATION. Revised: 12/2021

Warnings

Hyperglycemia or Hyperosmolar Hyperglycemic State: Monitor blood glucose and administer insulin as needed. (5.1) Hypersensitivity Reactions: Monitor for signs and symptoms and discontinue infusion if reactions occur. (5.2) Vein Damage and Thrombosis: Consider central vein when administering more than 5% dextrose or with an osmolarity of at least 900 mOsm/L or when there is peripheral vein irritation, phlebitis, and/or associated pain. (2.2, 5.3) Hyponatremia: Avoid in patients with or at risk for hyponatremia. If use cannot be avoided, monitor serum sodium concentrations. (5.4) Electrolyte Imbalance and Fluid Overload: Avoid in patients with or at risk for fluid and/or solute overloading. …

Effets secondaires possibles

The most common adverse reactions are, hyperglycemia, hypersensitivity reactions, hyponatremia, infection both systemic and at the injection site, vein thrombosis or phlebitis, and electrolyte imbalance. (6) To report SUSPECTED ADVERSE REACTIONS, contact Fresenius Kabi USA, LLC at 1-800-551- 7176 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Pregnancy and breastfeeding

8.1 Pregnancy Risk Summary Appropriate administration of 10% Dextrose Injection during pregnancy is not expected to cause adverse developmental outcomes, including congenital malformations. Animal reproduction studies have not been conducted with injectable dextrose solutions. The estimated background risk of major birth defects and miscarriage for the indicated population is unknown. …

If you take too much

An increased infusion rate of 10% Dextrose Injection or administration of dextrose solutions can cause hyperglycemia, hyperosmolality, and adverse effects on water and electrolyte balance [see Warnings and Precautions (5.1, 5.5)]. Severe hyperglycemia and severe dilutional hyponatremia, and their complications, can be fatal. Discontinue infusion, reduce dose and institute appropriate corrective measures such as administration of exogenous insulin. …

En cas d'oubli

Prenez-le dès que vous y pensez, sauf s'il est presque l'heure de la dose suivante. Dans ce cas, sautez la dose oubliée. Ne prenez jamais deux doses à la fois pour compenser. Vérifiez votre notice, certains médicaments font exception.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2026-03-16.

Label for 10% DEXTROSE INFUSION $, the active ingredient registered with NAFDAC.

Check your pack of 10% DEXTROSE INFUSION $

Add the expiry date on your pack for a full Trust Score.

Ou prenez la boîte en photo
Encore 3 vérifications gratuites aujourd'hui Sources officielles : FDA américaine · EMA (UE) · NAFDAC · alertes OMS

About 10% DEXTROSE INFUSION $

What is in 10% DEXTROSE INFUSION $?

10% DEXTROSE INFUSION $ contains Dextrose Anhydrous (10%), as solution for infusion, according to its NAFDAC registration record.

Is 10% DEXTROSE INFUSION $ registered with NAFDAC?

Yes. 10% DEXTROSE INFUSION $ is listed on the NAFDAC register under registration number A11-0237, and its registration is active as of 1 November 2026.

Has 10% DEXTROSE INFUSION $ been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches 10% DEXTROSE INFUSION $ in our automatically synced alert list.

How can I check that my pack of 10% DEXTROSE INFUSION $ is genuine?

Run a free authenticity scan with the NAFDAC number A11-0237, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take 10% DEXTROSE INFUSION $?

Follow your prescription or the leaflet in your pack. The official label says: 2.1 Important Administration Instructions 10% Dextrose Injection is intended for intravenous use. Peripheral administration of 5% dextrose is generally acceptable, however, consider central vein when administering more than 5% dextrose or with an osmolarity of at least 900 mOsm/L or when there is peripheral vein irritation, phlebitis, and/or associated pain [see Warnings and Pr…

What is 10% DEXTROSE INFUSION $ used for?

1. INDICATIONS AND USAGE 10% Dextrose Injection is indicated as source of water and calories. (Summarised from the official U.S. FDA label for 10% DEXTROSE INFUSION $. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used 10% DEXTROSE INFUSION $? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.